A practical reference on Heptapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-25 and is reviewed periodically as new material appears.
Routine characterization relies on reversed-phase high-performance liquid chromatography to establish purity and on mass spectrometry to confirm molecular identity. Electrospray ionization and matrix-assisted laser desorption ionization are both used for mass verification. Amino acid analysis and peptide mapping can detect sequence errors. Common impurities include truncated sequences, methionine sulfoxide formed by oxidation, and deamidated products. Chromatograms are usually recorded near 214 nm, where the peptide backbone absorbs, and purity is reported as the percentage area of the principal peak.
Verification of a supplied batch generally combines a certificate of analysis with independent testing, because certificates are self-reported documents. A typical package includes a chromatographic trace, a mass spectrum, and a stated water or counter-ion content. Batch-to-batch consistency matters more than a single purity figure when results are compared across experiments. No single mandatory standard governs research-grade peptide release, so laboratories are expected to define their own acceptance criteria. Residual trifluoroacetate from purification is a frequently overlooked counter-ion.
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
| Property | Value | Notes |
|---|---|---|
| Typical purity | 95% or higher | By reversed-phase HPLC area |
| Identity method | Electrospray mass spectrometry | Confirms molecular mass |
| Purity method | Reversed-phase HPLC | Detection near 214 nm |
| Primary degradation | Methionine oxidation | Sulfoxide product, +16 Da |
| Solution storage | 2-8 °C, short term | Aliquot to avoid freeze-thaw |
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.
=== August === 1 August – Stella Maris, the Rector of the University of St Andrews, is removed from the university's governing body over a letter she sent to students shortly after taking office in which she called for an immediate ceasefire in Gaza and referred to "genocidal attacks" made by the Israeli government. She will remain as Rector until October 2026, when her term ends. 4 August – A yellow weather warning is issued for heavy rain and strong winds in parts of Scotland, which is active until 9pm the following day. 6 August – Fiona Robertson, the chief executive of the Scottish Qualifications Authority, apologises after around 7,000 students who took their Higher examinations received blank emails instead of their results. The results were later sent by text message. 8 August – Cosla puts forward a new offer of a 3.6% increase for all grades of refuse workers in a bid to prevent strikes in 26 of Scotland's 32 council areas. The offer would represent a rise of £1,292 for the lowest paid, equivalent to a 5.63% increase. 8–12 August – The 82nd World Science Fiction Convention takes place in Glasgow. 9 August – 2024 United Kingdom riots: Police Scotland announces it is sending 120 of their officers to Belfast to help deal with ongoing riots in the city. 12 August – Unison, Unite and the GMB suspend planned strikes by refuse collectors following a new offer from Cosla. 13 August – Scotland's gender service for young people, based in Glasgow, announces it will stop accepting self-referrals.
A fascial compartment is a section within the body that contains muscles and nerves and is surrounded by fascia. In the human body, the limbs can each be divided into two segments. The upper limb can be divided into the arm and the forearm; their sectional compartments are the fascial compartments of the arm and the fascial compartments of the forearm, which both contain an anterior and a posterior compartment. The lower limbs can also be divided into two segments: the leg and the thigh; those contain the fascial compartments of the leg and the fascial compartments of the thigh respectively.
The principal goal of the fat acceptance movement is to decrease discrimination against people who are overweight and obese. However, some in the movement are also attempting to challenge the established relationship between obesity and negative health outcomes. A number of organizations exist that promote the acceptance of obesity. They have increased in prominence in the latter half of the 20th century. The US-based National Association to Advance Fat Acceptance (NAAFA) was formed in 1969 and describes itself as a civil rights organization dedicated to ending size discrimination. The International Size Acceptance Association (ISAA) is a non-governmental organization (NGO) which was founded in 1997. It has more of a global orientation and describes its mission as promoting size acceptance and helping to end weight-based discrimination. These groups often argue for the recognition of obesity as a disability under the US Americans With Disabilities Act (ADA). The American legal system, however, has decided that the potential public health costs exceed the benefits of extending this anti-discrimination law to cover obesity.
For use topically on the skin, eye, and mucous membranes. Topical corticosteroids are divided in potency classes I to IV in most countries (A to D in Japan). Seven categories are used in the United States to determine the level of potency of any given topical corticosteroid.
== History == The Roman anatomist Galen commented on Hippocrates' work, classifying teeth as bones, noting their distinct characteristics compared to other bones. He was the first to discover nerves in teeth and identified seven cranial nerves in his research.
Sources: en.wikipedia.org
Propargylglycine and β-cyanoalanine are two irreversible inhibitors of cystathionase used to treat elevated H2S levels. Mechanistically, the amino group of propargylglycine attacks the aldimine to form an external aldimine. The β position of the alkyne is then deprotonated to form the allene, which is then attacked by the phenol of Tyr114. The internal aldimine can regenerate, but the newly created vinyl ether sterically hinders the active site, blocking cysteine from attacking pyridoxal phosphate.
== Format == Each episode is adapted from a corresponding story by fan fiction author Squirrelking that was posted on the website FanFiction.net. The original text of the story is narrated over video captured in the game Garry's Mod, often with accompanying music and sound effects. Each episode is voiced by a different narrator, each credited by an online handle.
== Localisation and precursors == Systemin and AtPEP1 are found in the cell cytosol. The precursor to tomato systemin is transcribed as a 200 amino acid polypeptide. It does not contain a putative signal sequence suggesting that it is synthesised on free ribosomes in the cytosol. The precursor to AtPEP1 is a 92 amino acid polypeptide and also lacks a signal sequence. In tomato, mRNA encoding the precursor for systemin is present at very low levels in unwounded leaves but accumulates upon wounding, particularly in the cells surrounding the sieve elements of the phloem in vascular bundles of mid veins. The precursor accumulates exclusively in the phloem parenchyma cells of leaves in tomato after wounding. The precursor to potato systemin is also localised in a similar manner suggesting it is under the same cell-type-specific regulation in both species. HypSys are localised in the cell wall. The precursor for tobacco HypSys is transcribed as a 165 amino acid polypeptide which has no structural homology to the precursor for systemin in tomato. The structural properties of HypSys, containing hydroxyproline and being glycosylated, indicate that they are synthesised through the secretory system. The precursor to HypSys in tomato is a 146 amino acid polypeptide, exclusively synthesised within the vascular bundles of leaves and petioles associated with parenchyma cells of phloem bundles. Unlike systemin, it is primarily associated with the cell wall. The precursors to HypSys appear to represent a distinct subfamily of hydroxyproline-rich proteins found in cell walls.
Like most KWS institute directors, Haber had accrued a large discretionary fund. It was his wish that it be distributed to the dismissed staff to facilitate their emigration. Hahn brokered a deal whereby 10 per cent of the funds would be allocated to Haber's people and the rest to KWS, but the Rockefeller Foundation insisted that the funds be used for their original scientific research or else be returned. In August 1933 the administrators of the KWS were alerted that several boxes of Rockefeller Foundation-funded equipment were about to be shipped to Herbert Freundlich, one of the department heads that Hahn had dismissed, who was now working in England. Ernst Telschow, a Nazi Party member, was in charge while Planck, the president of the KWS since 1930, was on vacation, and he ordered the shipment halted. Hahn complied, but he disagreed with the decision on the grounds that funds from abroad should not be diverted to military research, which the KWS was increasingly undertaking. When Planck returned from vacation, he ordered Hahn to expedite the shipment. Haber died on 29 January 1934. A memorial service was held on the first anniversary of his death. University professors were forbidden to attend, so they sent their wives in their place. Hahn, Planck and Joseph Koeth attended, and gave speeches. The ageing Planck did not seek re-election, and was succeeded in 1937 as president by Carl Bosch, a winner of the Nobel Prize in Chemistry and the chairman of the board of IG Farben, a company which had bankrolled the Nazi Party since 1932. Telschow became Secretary of the KWS.
The US's UEP guidelines suggest that in egg laying strains of chickens, the length of the upper beak distal from the nostrils that remains following trimming, should be 2 to 3 mm. In the UK, the Farm Animal Welfare Council stated: "The accepted procedure is to remove not more than one third of the upper and lower beaks or not more than one third of the upper beak only" but went on to recommend: "Where beak trimming is carried out, it should, wherever possible, be restricted to beak tipping; that is the blunting of the beak to remove the sharp point which can be the cause of the most severe damage to other birds."
Sources: en.wikipedia.org
Dry powder is normally held at -20 °C or lower, away from light and moisture. Sealed vials can also be kept at 2-8 °C for shorter intervals. Warming to room temperature before opening prevents condensation.
In solution, hydrolysis of peptide bonds and oxidation of the methionine residue are the principal concerns. Oxidation converts methionine to its sulfoxide form, shifting the mass by sixteen daltons. Both processes are slowed by cold storage and by avoiding alkaline conditions.
A certificate documents what the supplier measured on a specific lot, not how a laboratory will use the material. Independent verification of identity and purity is common practice. Acceptance criteria should be defined before a batch is ordered.
It is a synthetic seven-amino-acid peptide built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It belongs to the family of short ACTH fragments studied for nervous-system effects. Its backbone contains only standard amino acids.